Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Solomon Habtemariam and Masoud Khataminia.
Solomon Habtemariam
Connection Strength
0.169
Masoud Khataminia
  1. The prophylaxis and treatment potential of supplements for COVID-19. Eur J Pharmacol. 2020 Nov 15; 887:173530.
    View in: PubMed
    Score: 0.056
  2. Neutrophil elastase inhibitor (sivelestat) may be a promising therapeutic option for management of acute lung injury/acute respiratory distress syndrome or disseminated intravascular coagulation in COVID-19. J Clin Pharm Ther. 2020 Dec; 45(6):1515-1519.
    View in: PubMed
    Score: 0.056
  3. Pharmacological treatments of COVID-19. Pharmacol Rep. 2020 Dec; 72(6):1446-1478.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.